Specifically, LXRα and the ABC-cholesterol transporter; ABCA1, a direct target gene of LXR, were significantly upregulated in TNBC tumor-resident immune cells (Fig. 1C, Supplementary Fig. S1B). The gene discussed is ABCA1; the disease is neoplasm.